Qube Research & Technologies LTD Sonoma Pharmaceuticals, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Sonoma Pharmaceuticals, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 3,400 shares of SNOA stock, worth $14,008. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,400Holding current value
$14,008% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SNOA
# of Institutions
19Shares Held
435KCall Options Held
0Put Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il195KShares$804,0460.0% of portfolio
-
Geode Capital Management, LLC Boston, MA86.6KShares$356,9730.0% of portfolio
-
Jane Street Group, LLC New York, NY45.3KShares$186,6150.0% of portfolio
-
State Street Corp Boston, MA24.3KShares$100,1770.0% of portfolio
-
Hrt Financial LP New York, NY21.5KShares$88,6580.0% of portfolio
About Sonoma Pharmaceuticals, Inc.
- Ticker SNOA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,100,940
- Market Cap $12.8M
- Description
- Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription ...